Verde Bio Holdings, Inc.
VBHI · OTC
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.02 | 0.00 |
| FCF Yield | -42.33% | -27.85% | -56.77% | -23.27% |
| EV / EBITDA | -2.29 | -5.53 | -4.45 | -3.33 |
| Quality | ||||
| ROIC | -116.97% | -13.15% | -16.17% | -15.44% |
| Gross Margin | 17.77% | 8.09% | 5.45% | 35.98% |
| Cash Conversion Ratio | 0.21 | 0.72 | 1.23 | 0.35 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.89% | 19.43% | 91.30% | 167.25% |
| Free Cash Flow Growth | -30.81% | 47.47% | -161.10% | 47.47% |
| Safety | ||||
| Net Debt / EBITDA | -0.15 | -2.23 | -1.29 | -0.94 |
| Interest Coverage | 0.00 | -28.00 | -449.11 | -15.39 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -258.48 | -185.61 | -130.07 | -257.52 |